Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 23;63(S03):S1-S73.

Citicoline: pharmacological and clinical review, 2016 update

[Article in Spanish, English]
Affiliations
  • PMID: 28417449
Review

Citicoline: pharmacological and clinical review, 2016 update

[Article in Spanish, English]
J J Secades. Rev Neurol. .

Abstract

This review is based on the previous one published in 2010 -Secades JJ. Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62-, incorporating 183 new references, having all the information available to facilitate the access to the information in one document. This review is focused on the main indications of the drug, as acute stroke and its sequelae, including the cognitive impairment, and traumatic brain injury and its sequelae. There are retrieved the most important experimental and clinical data in both indications.

Title: Citicolina: revision farmacologica y clinica, actualizacion 2016.

Esta revision se basa en la publicada en 2010 –Secades JJ. Citicolina: revision farmacologica y clinica, actualizacion 2010. Rev Neurol 2011; 52 (Supl 2): S1-62– e incorpora 183 nuevas referencias aparecidas desde entonces, con lo que se organiza toda la informacion disponible para facilitar el acceso a dicha informacion en un unico documento. La revision se centra en las principales indicaciones del farmaco, como son los accidentes cerebrovasculares agudos y sus secuelas, incluyendo el deterioro cognitivo, y los traumatismos craneoencefalicos y sus secuelas. Se recogen los principales aspectos experimentales y clinicos en estas indicaciones.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

Substances